studygraphics

#VisualAbstract: Double sequential external defibrillation and vector-change defibrillation improve outcomes in patients with refractory ventricular fibrillation

Dec 11, 2022

1. Compared to standard defibrillation, patients with refractory ventricular fibrillation who...

#VisualAbstract: Vitamin D supplementation is not preventative for statin-associated muscle symptoms or statin discontinuation

Dec 11, 2022

1. A randomized controlled trial found that pretreatment with supplemental vitamin D did not...

#VisualAbstract: Early mobilization after ICU mechanical ventilation does not improve survival

Dec 1, 2022

1. Early mobilization of patients after mechanical ventilation in the intensive care unit (ICU)...

#VisualAbstract: All-oral regimen with delamanid, linezolid, levofloxacin, and pyrazinamide is effective for fluoroquinolone-sensitive multidrug-resistant tuberculosis

Nov 30, 2022

1. At 24 months, treatment success rate was numerically greater in the shorter-regimen group...

#VisualAbstract: Intensive blood pressure control post-endovascular thrombectomy after acute ischemic stroke linked with worse clinical outcomes

Nov 28, 2022

1. More intensive blood pressure targets were associated with poor functional outcome at 90 days,...

#VisualAbstract: Shorter antibiotic course non-inferior to longer course for pediatric community-acquired pneumonia

Nov 28, 2022

1. In a systematic review and meta-analysis, shorter courses of antibiotics were non-inferior in...

#VisualAbstract: Differences in oxygen saturation targets do not impact clinical outcomes in those receiving mechanical ventilation

Nov 19, 2022

Click here to read this study in NEJM

#VisualAbstract: Early mobilization does not improve outcomes in mechanically ventilated patients admitted to critical care

Nov 19, 2022

Click here to read this paper in NEJM.

#VisualAbstract: Psilocybin can reduce depressive symptoms in patients with treatment-resistant depression

Nov 19, 2022

Click here to read this study in NEJM.

#VisualAbstract: Renal artery denervation is effective and well-tolerated for blood pressure reduction

Nov 17, 2022

1. Patients assigned to renal artery denervation had significantly lower office and ambulatory...

#VisualAbstract: Second-line immunosuppression associated with worse outcomes for immune-related adverse events in melanoma

Nov 17, 2022

1. Median overall survival was longer in patients receiving steroid-only treatment for adverse...

#VisualAbstract: Treatment with empagliflozin reduced progression of chronic kidney disease

Nov 12, 2022

Click here to read this study in NEJM

#VisualAbstract: Selective decontamination of digestive tract does not result in reduction of in-hospital mortality

Nov 11, 2022

Click here to read this study in JAMA.

#VisualAbstract: Treatment with semaglutide reduced body mass index in adolescents with obesity

Nov 11, 2022

Click here to read this study in NEJM

#VisualAbstract: Pemafibrate does not reduce cardiovascular risk in patients with type 2 diabetes and elevated triglycerides

Nov 11, 2022

Click here to read this study in NEJM.

#VisualAbstract: Timing of daily antihypertensives does not change cardiovascular outcomes

Nov 11, 2022

1. The primary composite cardiovascular endpoint was similar among patients in the evening and...

#VisualAbstract: Methylprednisolone prophylaxis for cardiac surgery in infants with congenital heart disease does not improve outcomes

Nov 11, 2022

Click here to read this paper in NEJM.

#VisualAbstract: COVID-19 vaccination is safe during pregnancy and has benefits for neonatal outcomes

Nov 11, 2022

1. In a systematic review with meta-analysis, COVID-19 vaccination during pregnancy was associated...

#VisualAbstract: Continuous glucose monitoring in type 1 diabetes results in improved blood glucose levels

Oct 31, 2022

1. In patients with type 1 diabetes, using intermittently scanned continuous glucose monitoring...

#VisualAbstract: Continued enzalutamide after progression of metastatic prostate cancer improves progression-free survival

Oct 27, 2022

1. The median progression-free survival was higher in the enzalutamide vs the placebo group (9.5...

Follow Us

studygraphics